Medical Case Report
Patient ID: 678901
Name: Emily Carter
Age: 24
Gender: Female
Date of Report: 2025-01-15

Chief Complaint:
The patient reports experiencing intermittent abdominal pain, diarrhea, and unintentional weight loss of 8 lbs over the past three months. Symptoms are accompanied by fatigue and occasional blood in the stool.

Medical History:

Family History:
Mother has Crohn’s disease; father has no significant medical history.

Personal Medical History:
No prior history of gastrointestinal issues. Diagnosed with iron-deficiency anemia at age 22.

Lifestyle Factors:
The patient is a university student, follows an irregular diet due to academic stress, and consumes coffee daily. Denies smoking or alcohol use.

Medications:
Oral iron supplements (325 mg daily), occasional ibuprofen for headaches.

Recent Lab and Diagnostic Results:
Complete Blood Count (CBC): Hemoglobin 10.2 g/dL, hematocrit 32%, MCV 74 fL (microcytic anemia).
Fecal Calprotectin: Elevated at 250 µg/g (indicating inflammation).
Colonoscopy: Evidence of inflamed and ulcerated patches in the terminal ileum.
Biopsy Results: Granulomas consistent with Crohn's disease.
C-Reactive Protein (CRP): 15 mg/L (elevated).

Physical Examination Findings:
Vital Signs: Blood pressure 118/76 mmHg, heart rate 90 bpm, BMI 20.1.
Abdominal Exam: Mild tenderness in the right lower quadrant, no palpable masses or organomegaly.
Other Systems: Normal findings.

Impression:
The findings suggest Crohn's Disease with active inflammation in the terminal ileum. The condition aligns with the patient’s symptoms of abdominal pain, diarrhea, weight loss, and anemia.

Management Plan:
Medical Therapy:
Start budesonide (9 mg daily) for acute inflammation.
Consider azathioprine for maintenance therapy.
Continue iron supplementation for anemia.

Lifestyle Modifications:
Referral to a dietitian for a low-residue diet during flare-ups.
Encourage regular meals and hydration.

Follow-up:
Monitor symptoms and inflammatory markers (CRP, fecal calprotectin) after 6 weeks of therapy.
Schedule a follow-up colonoscopy in 12 months.
